<body><a name="drugname"></a><table class="topbox" width="100%">
<tr>
<td><span class="topboxgenname">AMOXICILLIN AND CLAVULANATE POTASSIUM</span><br/>(a-mox-i-sill'in)<br/><span class="topboxtradename">Augmentin, </span><span class="topboxtradename">Augmentin-ES600, </span><span class="topboxtradename">Augmentin XR, </span><span class="topboxtradename">Clavulin <img border="0" src="../images/maple.gif"/><br/></span><b>Classifications:</b> <span class="classification">antiinfective</span>; <span class="classification">beta-lactam antibiotic</span>; <span class="classification">aminopenicillin</span><br/><b>Prototype: </b>Ampicillin<br/><b>Pregnancy Category: </b>B<br/></td>
</tr>
</table>
<h1><a name="avail">Availability</a></h1>
<p>250 mg, 500 mg, 875 mg tablets; 125 mg, 200 mg, 400 mg chewable tablets; 125 mg/5 mL, 200 mg/5 mL, 250 mg/5 mL, 400 mg/5 mL, 600 mg/5 mL oral suspension; 1000 mg amoxicillin/62.5 mg clavulanate sustained-release tablets</p>
<h1><a name="action">Actions</a></h1>
<p>Used alone, clavulanic acid antibacterial activity is weak. In combination, it inhibits enzyme (beta-lactamase) degradation
         of amoxicillin and by synergism extends both spectrum of activity and bactericidal effect of amoxicillin against many strains
         of beta-lactamase-producing bacteria resistant to amoxicillin alone.
      </p>
<h1><a name="therapef">Therapeutic Effects</a></h1>
<p>Semisynthetic broad-spectrum antibiotic with fixed combination of amoxicillin, an aminopenicillin, and the potassium salt
         to clavulanic acid, a competitive beta-lactamase inhibitor. Active against gram-positive bacteria including <i>Staphylococcus aureus, Streptococcus pneumoniae, Clostridium, Peptococcus, Bacteroides fragilis</i> group, and many gram-negative organisms including <i>Branhamella catarrhalis </i>(formerly<i> Neisseria catarrhalis), Haemophilus influenzae, Proteus mirabilis; Salmonella, Shigella,</i> and <i>Klebsiella sp.</i> Generally inactive against <i>Pseudomonas</i>.
      </p>
<h1><a name="uses">Uses</a></h1>
<p>Infections caused by susceptible beta-lactamase-producing organisms: lower respiratory tract infections, acute bacterial sinusitis,
         community acquired pneumonia, otitis media, sinusitis, skin and skin structure infections, and UTI.
      </p>
<h1><a name="contrain">Contraindications</a></h1>
<p>Combination shares toxic potential of ampicillin. Hypersensitivity to penicillins; infectious mononucleosis.</p>
<h1><a name="precaution">Cautious Use</a></h1>
<p>Pregnancy (category B), lactation.</p>
<h1><a name="rtedsg">Route &amp; Dosage</a></h1>
<table cellpadding="4" cellspacing="0" class="rdbox" width="100%">
<tr>
<td><span class="indicationtitle">Mild to Moderate Infections</span><br/><span class="rdage">Adult:</span> <span class="rdroute">PO</span> 250 or 500 mg tablet (each with 125 mg clavulanic acid) q812h; Sustained-release tabs: 2 tablets (2000 mg amoxicillin/125
               mg clavulanate) q12h <small>x</small> 710 d<br/><span class="rdage">Child:</span> <span class="rdroute">PO</span> 40 kg, 2040 mg/kg/d (based on amoxicillin component) divided q812h; <i>&gt;3 mo,</i> 90 mg/kg/d of 600 ES divided q12h <small>x</small> 10 d<br/><span class="rdage">Neonate/</span><span class="rdage">Infant:</span> <span class="rdroute">PO</span> 3 mo, 30 mg/kg/d (amoxicillin) divided q12h<br/></td>
</tr>
</table>
<h1><a name="admintn">Administration</a></h1><span class="adminroutetype">Oral</span><br/><ul>
<li>Give at the start of a meal to minimize GI upset and enhance absorption.</li>
<li>Note that both 250- and 500-mg tablets contain the exact amount of clavulanic acid (125 mg and potassium salt); therefore,
            two 250-mg tablets are not equivalent to one 500-mg tablet.
         </li>
<li>Reconstitute oral suspension by adding amount of water specified on container to provide a 5 mL suspension. Tap bottle before
            adding water to loosen powder, then add water in 2 portions, agitating suspension well before each addition.
         </li>
<li>Agitate suspension well just before administration of each dose.</li>
<li>Give dialysis patient an additional 2 doses on the day of dialysis; one dose before and another dose after dialysis.</li>
<li>Store tablets in tight containers at 
      </li></ul>
<h1><a name="adverse">Adverse Effects (<img src="../images/special/greaterorequal.gif"/>1%)</a></h1><span class="typehead"> GI:</span>
<span class="speceff-common">Diarrhea,</span> nausea, vomiting. <span class="typehead">Skin:</span> Rash, urticaria. <span class="typehead">Other:</span> Candidal vaginitis; moderate increases in serum ALT, AST; glomerulonephritis; <span class="speceff-life">agranulocytosis</span> (rare). 
      <h1><a name="dtintefer">Diagnostic Test Interference</a></h1>
<p>May interfere with <span class="alt">urinary glucose</span> determinations using <span class="alt">cupric sulfate,</span>
<span class="alt">Benedict's solution,</span>
<span class="alt">Clinitest;</span> does not affect <span class="alt">glucose oxidase methods</span> (e.g., Clinistix, TesTape). Positive direct <span class="alt">antiglobulin</span> (<span class="alt">Coombs'</span>) test results may be reported, a reaction that could interfere with <span class="alt">hematologic studies</span> or with <span class="alt">transfusion cross-matching</span> procedures.
      </p>
<h1><a name="interactions">Interactions</a></h1><span class="typehead"> Drug:</span>
<span class="classification">tetracyclines</span> may inhibit activity of amoxicillin; <b>probenecid</b> prolongs the activity of amoxicillin. 
      <h1><a name="pharmaks">Pharmacokinetics</a></h1><span class="typehead">Absorption:</span> Rapid and nearly complete absorption.  <span class="typehead">Peak:</span> 12 h.  <span class="typehead">Distribution:</span> Diffuses into most tissues and body fluids, except synovial fluid and CSF (unless meninges are inflamed); crosses placenta;
      distributed into breast milk in very small amounts.  <span class="typehead">Metabolism:</span> Metabolized in liver. <span class="typehead"> Elimination:</span> 5073% of the amoxicillin and 2545% of the clavulanate dose excreted in urine in 2 h. <span class="typehead">Half-Life:</span> Amoxicillin 11.3 h, clavulanate 0.781.2 h. 
      <h1><a name="nursing"><span class="implictitle">Nursing Implications</span></a></h1>
<p><span class="adeffecttitle">Assessment &amp; Drug Effects</span></p>
<ul>
<li>Determine previous hypersensitivity reactions to penicillins, cephalosporins, and other allergens prior to therapy.</li>
<li>Lab tests: Baseline C&amp;S tests prior to initiation of therapy; start drug pending results.</li>
<li>Monitor for S&amp;S of an urticarial rash (usually occurring within a few days after start of drug) suggestive of a hypersensitivity
            reaction. If it occurs, look for other signs of hypersensitivity (fever, wheezing, generalized itching, dyspnea), and report
            to physician immediately.
         </li>
<li>
            							Note: Generalized, erythematous, maculopapular rash (ampicillin rash) is not due to hypersensitivity. It is usually mild, but can
            be severe. Report onset of rash to physician, since hypersensitivity should be ruled out.
            						
         </li>
</ul>
<p><span class="eductitle">Patient &amp; Family Education</span></p>
<ul>
<li>Female patients should report onset of symptoms of <i>Candidal vaginitis</i> (e.g., moderate amount of white, cheesy, nonodorous vaginal discharge; vaginal inflammation and itching; vulvar excoriation,
            inflammation, burning, itching). Therapy may have to be discontinued.
         </li>
<li>
            							Note: Use Clinistix or TesTape when monitoring urinary glucose to avoid false readings with diabetes mellitus.
            						
         </li>
<li>Do not breast feed while taking this drug without consulting physician.</li>
</ul>
<hr/>
<p><span class="footer">Common adverse effects in <i>italic</i>, life-threatening effects <u>underlined</u>; generic names in <b>bold</b>; classifications in <small>SMALL CAPS</small>; <img border="0" src="../images/maple.gif"/> Canadian drug name; <img border="0" src="../images/pr.gif"/> Prototype drug</span></p>
</body>